Ondine Biomedical (OBI) Competitors C$13.75 0.00 (0.00%) As of 05:33 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock OBI vs. BTG, ABC, GNS, ONT, OXB, ERGO, SLN, PRTC, HZD, and AVCTShould you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include BTG (BTG), Abcam (ABC), Genus (GNS), Oxford Nanopore Technologies (ONT), Oxford Biomedica (OXB), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), and Avacta Group (AVCT). These companies are all part of the "biotechnology" industry. Ondine Biomedical vs. Its Competitors BTG Abcam Genus Oxford Nanopore Technologies Oxford Biomedica Ergomed Silence Therapeutics PureTech Health Horizon Discovery Group plc (HZD.L) Avacta Group Ondine Biomedical (LON:OBI) and BTG (LON:BTG) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation. Which has preferable valuation and earnings, OBI or BTG? BTG has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine BiomedicalC$2.05M3,478.55-C$424.66K-C$0.07-196.43BTG£914.10M0.00N/A£28.50N/A Is OBI or BTG more profitable? BTG has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. BTG's return on equity of 0.00% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine Biomedical-873.84% -684.01% -159.71% BTG N/A N/A N/A Does the media prefer OBI or BTG? In the previous week, BTG had 10 more articles in the media than Ondine Biomedical. MarketBeat recorded 10 mentions for BTG and 0 mentions for Ondine Biomedical. Ondine Biomedical's average media sentiment score of 0.00 beat BTG's score of -0.01 indicating that Ondine Biomedical is being referred to more favorably in the media. Company Overall Sentiment Ondine Biomedical Neutral BTG Neutral Do institutionals and insiders hold more shares of OBI or BTG? 9.7% of Ondine Biomedical shares are held by institutional investors. 37.4% of Ondine Biomedical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryBTG beats Ondine Biomedical on 7 of the 10 factors compared between the two stocks. Get Ondine Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBI vs. The Competition Export to ExcelMetricOndine BiomedicalBiotechnology IndustryMedical SectorLON ExchangeMarket CapC$7.13BC$231.95MC$6.10BC$2.61BDividend YieldN/A3.80%5.70%5.28%P/E Ratio-196.4394.8985.554,442.02Price / Sales3,478.556,125.17622.26100,236.46Price / Cash1.9913.1937.7827.90Price / Book1,592.42116.7513.139.02Net Income-C$424.66K-C$90.99MC$3.30BC$5.89B7 Day Performance-5.17%4.47%5.29%0.49%1 Month Performance-9.84%7.21%9.94%5.62%1 Year Performance113.18%742.62%87.78%164.56% Ondine Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOndine BiomedicalN/AC$13.75flatN/A+111.5%C$7.13BC$2.05M-196.43N/ABTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus2.0153 of 5 starsGBX 2,520+1.6%GBX 2,900+15.1%+20.5%£1.66B£672.80M-40,645.16480Gap DownONTOxford Nanopore Technologies2.4768 of 5 starsGBX 153-2.7%GBX 245+60.1%+1.9%£1.47B£204.69M-1,033.781,281News CoverageGap UpOXBOxford Biomedica1.4777 of 5 starsGBX 595+0.8%GBX 593.67-0.2%+63.9%£715.08M£151.21M-1,425.15891News CoverageAnalyst ForecastERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.7904 of 5 starsGBX 140+0.7%GBX 455+225.0%-9.3%£338.36M£6.17M823.53300Positive NewsHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416AVCTAvacta Group2.535 of 5 starsGBX 62.95+2.4%GBX 99+57.3%+47.3%£252.91M£113K-410.37120 Related Companies and Tools Related Companies BTG Competitors Abcam Competitors Genus Competitors Oxford Nanopore Technologies Competitors Oxford Biomedica Competitors Ergomed Competitors Silence Therapeutics Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Avacta Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:OBI) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
